Products - Dementia | Topic | NICE

Showing 4 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer’s disease [ID4043]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
5 February 2025
Donanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID6222]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
26 March 2025
Hydromethylthionine mesylate for treating mild cognitive impairment or mild or moderate dementia caused by Alzheimer's disease [ID6343]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
30 April 2025
Alzheimer's disease (early) - gantenerumab [ID6142]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC